Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Viatris Inc (VTRS) vs State Street SPDR S&P Homebuilders ETF (XHB) Price & Performance

Viatris IncTrade
State Street SPDR S&P Homebuilders ETFTrade

Price performance (Past 24H)

Key statistics

Viatris Inc vs State Street SPDR S&P Homebuilders ETF — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while State Street SPDR S&P Homebuilders ETF trades at $105.91. The key difference: Viatris Inc pays a 2.83% dividend while State Street SPDR S&P Homebuilders ETF pays none, and Viatris Inc is trading nearer its 52-week high, State Street SPDR S&P Homebuilders ETF nearer its low. Which is the better fit depends on your goals.

VTRSXHB
Market Cap
$19.79B
Sector
HealthBroad Market / Factor
52-Week High
$17.39$121.36
52-Week Low
$8.74$94.86
Enterprise Value
$32.00B
Dividend Yield
2.83%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS

About State Street SPDR S&P Homebuilders ETF

XHB invests in the U.S. homebuilding industry and related sectors. It provides equal-weighted exposure to homebuilders, building products, and home improvement retailers like Home Depot, Lowe's, and Builders FirstSource.

Read more on XHB